Related Experiment Video
Updated: Dec 27, 2025

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Minimum Inhibitory Concentrations of Vancomycin and Daptomycin Against Methicillin-resistant Staphylococcus Aureus
Vinay Kumar Moses1, Venkataramana Kandi2, Sanjeev Kumar D Rao3
1Microbiology, Government Medical College, Siddipet, IND.
Abstract:
Background Staphylococci are Gram-positive cocci arranged in clusters. They are colonized in humans and animals. Also, Staphylococcus aureus (S. aureus) is frequently associated with various superficial to deep-seated infections in humans. Due to the potential for easy transmission, Staphylococci are associated with both hospital-acquired and community-associated infections. Strains of S. aureus resistant to methicillin (MRSA) pose treatment challenges. In such cases, vancomycin is the treatment of choice. Due to the indiscriminate use of vancomycin, recently, we are seeing the emergence of vancomycin-intermediate sensitive S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA). The present study aims to evaluate the minimum inhibitory concentrations (MICs) of vancomycin and daptomycin among MRSA strains isolated from human clinical specimens Methods The study included 115 MRSA isolates collected over 26 months from July 2010 to September 2012. The strains were isolated from pus, urine, wound swabs, catheters, blood, and sputum. The bacteria were acquired from different inpatient and outpatient departments of Prathima Institute of Medical Sciences, Karimnagar, Telangana, India. Kirby-Bauer disk diffusion method using cefoxitin was used to confirm the MRSA isolates. The agar dilution and the Epsilometer method (E-test) were used to test the MICs of MRSA isolates against vancomycin and daptomycin, respectively, by the standard procedures recommended by the clinical laboratory standards institute (CLSI). Results Of the 115 S. aureus isolates, seven (6.08%) strains were resistant to vancomycin (VRSA) and 53 (46.08%) were found to be VISA using the new CLSI breakpoints. The MIC of the daptomycin was found to be ≤1 µg/ml for all the MRSA isolates. Conclusion The study results depicted an increasing trend in the vancomycin MICs among the MRSA isolates. Several tested strains show MICs in the intermediate sensitive range (VISA). The daptomycin was effective against all the MRSA isolates.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) infections show rising vancomycin resistance, with many strains becoming vancomycin-intermediate sensitive Staphylococcus aureus (VISA). Daptomycin remains effective against all tested MRSA strains, offering a viable treatment option.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Staphylococci, including Staphylococcus aureus (S. aureus), are common human and animal colonizers.
- S. aureus causes various infections and is transmitted easily, leading to hospital- and community-associated infections.
- Methicillin-resistant S. aureus (MRSA) presents treatment challenges, with vancomycin as a primary choice, but vancomycin-intermediate sensitive S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) are emerging.
Purpose of the Study:
- To evaluate the minimum inhibitory concentrations (MICs) of vancomycin and daptomycin against MRSA strains.
- To assess the prevalence of vancomycin resistance and intermediate sensitivity in MRSA isolates from clinical specimens.
Main Methods:
- Analysis of 115 MRSA isolates collected over 26 months (July 2010-September 2012) from various human clinical specimens.
- Confirmation of MRSA using the Kirby-Bauer disk diffusion method with cefoxitin.
- Determination of vancomycin and daptomycin MICs using agar dilution and E-test methods, respectively, following CLSI guidelines.
Main Results:
- Out of 115 S. aureus isolates, 7 (6.08%) were VRSA and 53 (46.08%) were VISA based on new CLSI breakpoints.
- Daptomycin showed an MIC of ≤1 µg/ml for all tested MRSA isolates, indicating consistent effectiveness.
Conclusions:
- A concerning trend of increasing vancomycin MICs among MRSA isolates was observed.
- A significant proportion of MRSA strains exhibited intermediate sensitivity to vancomycin (VISA).
- Daptomycin demonstrated universal effectiveness against the studied MRSA isolates, highlighting its potential as an alternative treatment.
Related Concept Videos
Estimation of k and VD of Aminoglycosides
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Antimicrobial Effectiveness
Combined Effects of Drugs: Synergism
Such synergistic combinations...

